Daxor Corporation

06/16/2025

🔍 When this 68-year-old's didn't respond to diuretics, we knew something was off. revealed the real diagnosis: Normovolemic Normocythemic acute decompensated HF.

❌ Standard diuretics weren't helping

✅ Treating diastolic dysfunction was the answer

💡The lesson? When patients don't respond as expected, question everything.

🎯Accurate phenotyping saves lives.

📖Read more here: https://linkedin.com/pulse/what-would-happen-we-stopped-assuming-all-heart-failure-cnive

06/12/2025

🔬 40% of "anemic" patients actually have dilutional pseudo-anemia, not true anemia. Standard tests can't tell the difference but can. Read more: https://www.linkedin.com/posts/daxorcorporation_heartfailure-bva-activity-7338601695335112704-d4vD?utm_source=share&utm_medium=member_desktop&rcm=ACoAABh7EWABqJPmyYdciYvicG7ZBxRMs4Vo7zQ
Duke Health

05/26/2025

Today we pause to honor the brave men and women who made the ultimate sacrifice for our freedom.

05/22/2025

Patients who were properly decongested - confirmed by - experienced significantly better one-year survival. This is a win for patients, and a step forward in personalizing care. Read more: https://www.linkedin.com/pulse/know-case-clear-precision-volume-measurement-improves-cgv1c/?trackingId=cP%2FyOcupT1qG5%2FUdmRqJqw%3D%3D

I am encouraged by the important new findings presented at ACC.25 which further validate the role of objective blood volume analysis (BVA) in heart failure management.

05/20/2025

New data from showed a 2.61-fold higher mortality risk in hypervolemic (congested) patients compared to euvolemic patients uniquely identified by . Read more: https://www.linkedin.com/pulse/true-euvolemia-matters-bva-study-202-patients-shows-significant-yq7re/?trackingId=mvtQuDSkT6yzxCkVWk447A%3D%3D
American College of Cardiology
Allina Health

05/16/2025

💙Join us in sending appreciation to the incredible ICU teams who provide extraordinary care during life's most critical moments.
Society of Critical Care Medicine (SCCM)

05/14/2025

New research highlights prevalence in patients, demonstrating 's value for accurately determining red blood cell profiles.
Read full story: https://daxor.com/daxor-announces-duke-university-study-on-blood-volume-analysis-in-heart-failure-published-in-american-heart-journal/
Nasdaq
Duke Health

05/13/2025

! Daxor continues to drive transformation through its dual implementation models, tailored to meet the unique needs of diverse clinical settings. Read more: https://daxor.com/daxors-blood-volume-analysis-diagnostic-reaches-two-new-u-s-healthcare-systems/
Nasdaq

05/10/2025

Our specialized nursing team are the backbone of our clinical education program. They expertly train prescribers on technology, helping them understand and interpret test results with confidence and precision.

05/07/2025

Another major win for and ! Leading hospitals nationwide adopting our precision diagnostic for fluid management in , , and patients. Read more: https://daxor.com/florida-healthcare-leader-embraces-daxor-blood-volume-analysis-technology/
Nasdaq

05/06/2025

💙👩‍⚕️👨‍⚕️Celebrating our healthcare heroes who blend compassion with clinical expertise. From ordering vital tests to providing comfort, nurses do it all. Thank you for your skill and heart!

05/06/2025

📰 ! We're expanding our capabilities to three new hospitals with our service - delivering precise results in 24hrs and driving strong sales as providers embrace both clinical and economic benefits. Read more: https://daxor.com/three-new-medical-centers-adopt-daxors-blood-volume-diagnostic-signaling-growing-clinical-acceptance/?utm_source=mailpoet&utm_medium=email&utm_source_platform=mailpoet
Nasdaq